During the past 12 months, Cryo-Cell International's average Revenue per Share Growth Rate was 3.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -0.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -1.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 8.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Cryo-Cell International was 97.80% per year. The lowest was -18.00% per year. And the median was 9.90% per year.
Competitive Comparison of Cryo-Cell International's 3-Year Revenue Growth Rate
For the Medical Care Facilities subindustry, Cryo-Cell International's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryo-Cell International's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's 3-Year Revenue Growth Rate falls into.
Cryo-Cell International 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Cryo-Cell International (AMEX:CCEL) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Cryo-Cell International 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of Cryo-Cell International's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryo-Cell International (Cryo-Cell International) Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCEL has been successfully added to your